Optimism abounds here, like it should, eh.
However, if this product was about to explode on the aesthetic market like all of you are hoping and predicting, how come all the BIG guys on the block are not even sniffing at this LaViv process.
Allergan even drove by the FCSC offices in PA to purchase a privately held concern with a product in stage 2 development.
Now this tells me, the BIG DAWGS' eminent scientists in R&D have checked this Laviv product out and deemed it not worth the money nor effort.
If Laviv was going to be a factor, you figure one of the BIG 3 wrinkle filler players would have bought in by now, to get the upper hand on the other two. You figure the current market cap of FCSC is pennies to the BIG players.
Yet, we are seeing what amounts to a HUGE snub! They just don't see any upside to the product.
Wouldn't you agree?